182 related articles for article (PubMed ID: 37307993)
1. Systemic calcineurin inhibitors tacrolimus and voclosporin: A review of off-label dermatologic uses.
Dai A; Kim SJ
J Am Acad Dermatol; 2024 Feb; 90(2):358-367. PubMed ID: 37307993
[TBL] [Abstract][Full Text] [Related]
2. Systemic ciclosporin and tacrolimus in dermatology.
Madan V; Griffiths CE
Dermatol Ther; 2007; 20(4):239-50. PubMed ID: 17970889
[TBL] [Abstract][Full Text] [Related]
3. How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not.
van Gelder T
Kidney Int; 2021 Dec; 100(6):1185-1189. PubMed ID: 34284043
[TBL] [Abstract][Full Text] [Related]
4. Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis.
van Gelder T; Lerma E; Engelke K; Huizinga RB
Expert Rev Clin Pharmacol; 2022 May; 15(5):515-529. PubMed ID: 35763288
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine in Dermatology.
Kutlubay Z; Erdogan BÇ; Engin B; Serdaroglu S
Skinmed; 2016; 14(2):105-9. PubMed ID: 27319953
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical Studies.
Li Y; Palmisano M; Sun D; Zhou S
Clin Pharmacol; 2020; 12():83-96. PubMed ID: 32669879
[TBL] [Abstract][Full Text] [Related]
7. Off-label dermatologic uses of IL-17 inhibitors.
Wu KK; Dao H
J Dermatolog Treat; 2022 Feb; 33(1):41-47. PubMed ID: 32116066
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Rovin BH; Solomons N; Pendergraft WF; Dooley MA; Tumlin J; Romero-Diaz J; Lysenko L; Navarra SV; Huizinga RB;
Kidney Int; 2019 Jan; 95(1):219-231. PubMed ID: 30420324
[TBL] [Abstract][Full Text] [Related]
9. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
10. Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders.
Guenther L; Lynde C; Poulin Y
J Cutan Med Surg; 2019; 23(4_suppl):27S-34S. PubMed ID: 31476936
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical calcineurin inhibitors in psoriasis.
Wang C; Lin A
J Cutan Med Surg; 2014; 18(1):8-14. PubMed ID: 24377467
[TBL] [Abstract][Full Text] [Related]
12. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review.
Dattola A; Silvestri M; Bennardo L; Del Duca E; Longo C; Bianchi L; Nisticò S
Dermatol Ther; 2018 Nov; 31(6):e12728. PubMed ID: 30295379
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease.
Carroll CL; Fleischer AB
Expert Opin Pharmacother; 2004 Oct; 5(10):2127-37. PubMed ID: 15461548
[TBL] [Abstract][Full Text] [Related]
14. [Tacrolimus in diseases other than atopic dermatitis].
Alomar A; Corella F; García-Navarro X
Actas Dermosifiliogr; 2008 Feb; 99 Suppl 2():26-35. PubMed ID: 18346427
[TBL] [Abstract][Full Text] [Related]
15. The use of cyclosporine in dermatology.
Dehesa L; Abuchar A; Nuno-Gonzalez A; Vitiello M; Kerdel FA
J Drugs Dermatol; 2012 Aug; 11(8):979-87. PubMed ID: 22859244
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of voclosporin for the treatment of lupus nephritis.
Sin FE; Isenberg D
Expert Opin Pharmacother; 2018 Oct; 19(14):1613-1621. PubMed ID: 30207816
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Rovin BH; Teng YKO; Ginzler EM; Arriens C; Caster DJ; Romero-Diaz J; Gibson K; Kaplan J; Lisk L; Navarra S; Parikh SV; Randhawa S; Solomons N; Huizinga RB
Lancet; 2021 May; 397(10289):2070-2080. PubMed ID: 33971155
[TBL] [Abstract][Full Text] [Related]
18. Innovative use of topical calcineurin inhibitors.
Lin AN
Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
[TBL] [Abstract][Full Text] [Related]
19. Off-label Uses of Topical Pimecrolimus.
Ladda M; Sandhu V; Ighani A; Yeung J
J Cutan Med Surg; 2019; 23(4):442-448. PubMed ID: 31053034
[TBL] [Abstract][Full Text] [Related]
20. A network meta-analysis of randomized controlled trials comparing the effectiveness and safety of voclosporin or tacrolimus plus mycophenolate mofetil as induction treatment for lupus nephritis.
Lee YH; Song GG
Z Rheumatol; 2023 Sep; 82(7):580-586. PubMed ID: 34545430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
